Celiac Disease Drug Development in the News

Stay up to date on advances in the development of alternative, non-dietary treatments in the celiac disease field. These articles from the Beyond Celiac Research News feed highlight the latest news and past milestones in the journey to find new treatments – or even a cure – for celiac disease.

Note: Prior to December 2015, Beyond Celiac was known as the National Foundation for Celiac Awareness. Learn more about the name change here.

 

Up to Half of Patients May Not Fully Respond to a Gluten-Free Diet

Landmark Meeting Identifies Pathway for New Celiac Disease Therapies

The Search for Treatment Beyond the Gluten-Free Diet

Newly Diagnosed ​with Celiac Disease ​and Living in New England? Advance​ Research in One Simple Step

New Research Study for Refractory Celiac Disease Looking for Participants

Celimmune Commences First-Ever Dosing with AMG 714 in Celiac Disease

Celimmune Commences Screening in Phase 2 Clinical Study in Refractory Celiac Disease Type II

ImmunogenX Acquires the Assets of Alvine Pharmaceuticals

Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics

Journal Gastroenterology Publishes Research Indicating Nearly Identical Response to Gluten in Most Children and Adults with Celiac Disease

Cour Pharmaceuticals Releases Data on Potential Breakthrough Treatment for Celiac Disease

One Step Closer to New Treatment Options for Celiac Disease

Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen

Celimmune Founded to Develop Novel Therapeutics for Celiac and Other Serious Autoimmune Diseases

Larazotide Acetate Shows Promising Results in Patients on Gluten-Free Diet with Persistent Symptoms

ImmusanT Recognized for Potential Celiac-Curing Vaccine

Journal of Autoimmunity Publishes Research Supporting Safety of Oats in the Celiac Diet

Breaking News! Gluten-Free Diet is Not Enough – Ongoing Intestinal Damage in Most Diagnosed Patients

Research Shows Promise for a Potential Future Treatment for Celiac Disease

Alba Therapeutics Announces Positive Results of Phase IIb Trial in Celiac Disease

National Study to Help Advance Celiac Disease Research

Alvine Pharmaceuticals Doses First Patient in Phase 2B Trial for ALV003 in Celiac Disease

Fusion Antibodies Announces Collaboration For New Refractory Celiac Disease Drug With Calypso Biotech

ImmusanT Begins Clinical Research Study to Explore Immunologic Relationship between Celiac Disease & Type 1 Diabetes

Potential Pharmaceutical Treatments for Celiac Disease: An Interview with Joseph Murray, MD

Showing 1-25 of 44
1 2   |   >

For more updates and summaries of research articles related to celiac disease and non-celiac gluten sensitivity, visit the Beyond Celiac Research News feed.

 

OUR SPONSORS & PARTNERS

Advertise with us

  • CrunchMaster: Happy, Healthy, & Gluten-Free
  • Allergic Living 10 dollars off
  • Three Bakers Gluten-Free: Find Your New Fave
  • Bake Freely
  • Rudi's Gluten-Free Recipes
  • Blue Diamond Gluten-Free Nut Thins
  • Gluten-Free Resource Directory